К содержанию
Dr. Tara EinullaevaMedical oncologist

Cancer glossary

BRCA1 and BRCA2 mutations: what your test result means

What BRCA1 and BRCA2 mean on your report: inherited vs tumor mutations, variants of uncertain significance, risks for carriers and the effect on treatment.

Written and medically reviewed by

Dr. Tara Einullaeva

Medical oncologist, 9 years in practice. Credentials · reviewed 17 October 2026

In short

BRCA1 and BRCA2 are genes that help cells repair damaged DNA. A harmful mutation raises the risk of breast, ovarian, prostate and pancreatic cancer, and in people who already have cancer it may open access to PARP inhibitors.

How it appears in your report

  • ‘Pathogenic variant c.5266dupC detected in BRCA1’ — a harmful mutation was found; the letters and numbers are its exact ‘address’.
  • ‘Likely pathogenic variant in BRCA2’ — in practice handled the same way as pathogenic.
  • ‘Variant of uncertain significance (VUS)’ — it is not yet known whether it is harmful.
  • ‘No pathogenic variants detected’ — a negative result.

Check the sample type: blood or saliva means a germline (inherited) test, tumor tissue means a somatic test. See the glossary entry on somatic and inherited mutations for the difference.

What it means

Lifetime cancer risk according to NCI:

Cancer General population BRCA1 BRCA2
Breast (women) about 13% over 60% over 60%
Ovarian about 1.1% 39–58% 13–29%
Pancreatic about 1.7% up to 5% 5–10%
Prostate (by age 80) about 10.6% 7–26% 19–61%

A mutation raises the risk, but it does not mean cancer will definitely develop.

Does it affect treatment

Yes. PARP inhibitors are used in breast cancer (HER2-negative, with an inherited mutation), ovarian, pancreatic and prostate cancer, each with its own conditions. Carrier status can also affect the extent of surgery. In 2024, ESMO noted that tumor NGS can replace germline BRCA1/2 testing in most patients; but if a mutation is found in the tumor, inherited testing is still discussed. Your treating doctor makes treatment decisions, and family prevention is planned with a genetic counselor.

Questions to ask your doctor

  • Was the test done on blood or on the tumor? Do I need the other one?
  • Does the result change my treatment now?
  • Should my relatives be tested, and where?

More in the article on BRCA testing. If you are not sure whether you need the test, we can discuss it in a consultation.

Sources

  1. BRCA Gene Changes: Cancer Risk and Genetic Testing — National Cancer Institute, 2024
  2. Olaparib — National Cancer Institute, accessed 2026
  3. When to perform next-generation sequencing test in patients with cancer? ESMO updates its recommendations — ESMO, 2024

Watch me explain this on video

Short videos on my Instagram (in Russian)

FAQ

Related terms

This is reference information and not a substitute for medical advice. Your doctor interprets each value in the context of your whole situation.

Related articles

All blog articles